PROVECTUS BIOPHARMACEUTICALS, INC. — Net Income by Fiscal Year
23 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1a0f9045-1753-40a0-b1a3-9eb72472d9ed/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $5.5M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-018081 |
| FY 2024 | $4.8M | 2024-01-01 – 2024-12-31 | evidence 0001493152-26-018081 |
| FY 2023 | $3.1M | 2023-01-01 – 2023-12-31 | evidence 0001493152-26-018081 |
| FY 2022 | $-3.6M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009563 |
| FY 2021 | $-5.5M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008016 |
| FY 2020 | $-6.7M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-005194 |
| FY 2019 | $-6.9M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-003433 |
| FY 2018 | $-8.2M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-002987 |
| FY 2017 | $-13.5M | 2017-01-01 – 2017-12-31 | evidence 0001493152-18-003771 |
| FY 2016 | $-24.4M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-106543 |
| FY 2015 | $-24.5M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-523701 |
| FY 2014 | $-10.2M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-088039 |
| FY 2013 | $-152.7M | 2002-02-01 – 2014-03-31 | evidence 0001193125-14-188810 |
| FY 2012 | $-122.5M | 2002-01-18 – 2013-03-31 | evidence 0001193125-13-211517 |
| FY 2011 | $-110.3M | 2002-01-16 – 2012-03-31 | evidence 0001193125-12-221968 |
| FY 2010 | $-18.6M | 2010-01-29 – 2010-12-31 | evidence 0000950123-11-074703 |
| FY 2009 | $-12.3M | 2009-01-01 – 2009-12-31 | evidence 0000950123-11-074703 |
| FY 2008 | $-10.3M | 2008-01-01 – 2008-12-31 | evidence 0000950123-11-074703 |
| FY 2007 | $-10.0M | 2007-01-01 – 2007-12-31 | evidence 0000950123-11-074703 |
| FY 2006 | $-8.9M | 2006-01-01 – 2006-12-31 | evidence 0000950123-11-074703 |
| FY 2005 | $-11.8M | 2005-01-01 – 2005-12-31 | evidence 0000950123-11-074703 |
| FY 2004 | $-4.3M | 2004-01-01 – 2004-12-31 | evidence 0000950123-11-074703 |
| FY 2003 | $-3.2M | 2003-01-01 – 2003-12-31 | evidence 0000950123-11-074703 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PROVECTUS BIOPHARMACEUTICALS, INC. — all facts · Revenue · Operating Income